{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:41:56Z","timestamp":1792456916203,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"DOI":"10.1038\/s44161-025-00611-7","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T10:03:29Z","timestamp":1739441009000},"page":"266-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Long-term survival and durable recovery of heart failure in patients with triglyceride deposit cardiomyovasculopathy treated with tricaprin"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3535-957X","authenticated-orcid":false,"given":"Ken-ichi","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5354-9687","authenticated-orcid":false,"given":"Koichiro","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8297-8624","authenticated-orcid":false,"given":"Kotaro","family":"Nochioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Iwanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Shimamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makito","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mana","family":"Okune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Shimoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimpei","family":"Kuniyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9973-6461","authenticated-orcid":false,"given":"Shu-Ping","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Zaima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7741-846X","authenticated-orcid":false,"given":"Kunihisa","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"611_CR1","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMc0805305","volume":"359","author":"K Hirano","year":"2008","unstructured":"Hirano, K., Ikeda, Y., Zaima, N., Sakata, Y. & Matsumiya, G. Triglyceride deposit cardiomyovasculopathy. N. Engl. J. Med. 359, 2396\u20132398 (2008).","journal-title":"N. Engl. J. Med."},{"key":"611_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.bbrc.2013.12.003","volume":"443","author":"K Hirano","year":"2014","unstructured":"Hirano, K. et al. Genetic mutations in adipose triglyceride lipase and myocardial up-regulation of peroxisome proliferated activated receptor-\u03b3 in patients with triglyceride deposit cardiomyovasculopathy. Biochem. Biophys. Res. Commun. 443, 574\u2013579 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"611_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13023-019-1087-4","volume":"14","author":"M Li","year":"2019","unstructured":"Li, M. et al. Triglyceride deposit cardiomyovasculopathy: a rare cardiovascular disorder. Orphanet J. Rare Dis. 14, 134\u2013142 (2019).","journal-title":"Orphanet J. Rare Dis."},{"key":"611_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/eurheartj\/ehu417","volume":"36","author":"K Hirano","year":"2015","unstructured":"Hirano, K., Ikeda, Y., Sugimura, K. & Sakata, Y. Cardiomyocyte steatosis and defective washout rate of iodine-123-\u03b2-methyl iodophenyl-pentadecanoic acid in genetic deficiency of adipose triglyceride lipase. Eur. Heart J. 36, 580 (2015).","journal-title":"Eur. Heart J."},{"key":"611_CR5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/eurheartj\/eht522","volume":"35","author":"Y Ikeda","year":"2014","unstructured":"Ikeda, Y., Hirano, K., Fukushima, N. & Sawa, Y. A novel type of human spontaneous coronary atherosclerosis with triglyceride deposition. Eur. Heart J. 35, 875 (2014).","journal-title":"Eur. Heart J."},{"key":"611_CR6","doi-asserted-by":"publisher","first-page":"100347","DOI":"10.1016\/j.jacadv.2023.100347","volume":"2","author":"K Hirano","year":"2023","unstructured":"Hirano, K. et al. Overall survival rate of patients with triglyceride deposit cardiomyovasculopathy. JACC Adv. 2, 100347 (2023).","journal-title":"JACC Adv."},{"key":"611_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.17996\/anc.22-00167","volume":"8","author":"H Miyauchi","year":"2022","unstructured":"Miyauchi, H. et al. 123I-BMIPP scintigraphy shows that CNT-01 (tricaprin) improved myocardial lipolysis in patients with idiopathic triglyceride deposit cardiomyovasculopathy: first randomized controlled, exploratory trial for TGCV. Ann. Nucl. Cardiol. 8, 67\u201375 (2022).","journal-title":"Ann. Nucl. Cardiol."},{"key":"611_CR8","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer, S. The failing heart\u2014an engine out of fuel. N. Engl. J. Med. 356, 1140\u20131151 (2007).","journal-title":"N. Engl. J. Med."},{"key":"611_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.17996\/anc.20-00131","volume":"6","author":"K Kobayashi","year":"2020","unstructured":"Kobayashi, K. et al. The diagnostic criteria 2020 for triglyceride deposit cardiomyovasculopathy. Ann. Nucl. Cardiol. 6, 99\u2013104 (2020).","journal-title":"Ann. Nucl. Cardiol."},{"key":"611_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12149-023-01863-8","volume":"38","author":"K Nakajima","year":"2024","unstructured":"Nakajima, K. et al. Practice recommendation for measuring washout rates in 123I-BMIPP fatty acid images. Ann. Nucl. Med. 38, 1\u20138 (2024).","journal-title":"Ann. Nucl. Med."},{"key":"611_CR11","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jaccas.2020.03.021","volume":"2","author":"P Rajani","year":"2020","unstructured":"Rajani, P. et al. ATGL deficiency-induced triglyceride deposit cardiomyovasculopathy requiring heart transplant: a 5-year follow-up. JACC Case Rep. 2, 760\u2013763 (2020).","journal-title":"JACC Case Rep."},{"key":"611_CR12","first-page":"100960","volume":"34","author":"Y Hara","year":"2023","unstructured":"Hara, Y. et al. A novel homozygous missense mutation in PNPLA2 in a patient with primary triglyceride deposit cardiomyovasculopathy. Mol. Genet. Metab. Rep. 34, 100960 (2023).","journal-title":"Mol. Genet. Metab. Rep."},{"key":"611_CR13","doi-asserted-by":"publisher","first-page":"27027","DOI":"10.1074\/jbc.270.45.27027","volume":"270","author":"N Hilaire","year":"1995","unstructured":"Hilaire, N., Salvayre, R., Thiers, J. C., Bonnaf\u00e9, M. J. & Negre-Salvayre, A. The turnover of cytoplasmic triacylglycerols in human fibroblasts involves two separated acyl chain length-dependent degradation pathways. J. Biol. Chem. 270, 27027\u201327034 (1995).","journal-title":"J. Biol. Chem."},{"key":"611_CR14","doi-asserted-by":"publisher","first-page":"983","DOI":"10.5650\/jos.ess18037","volume":"67","author":"A Suzuki","year":"2018","unstructured":"Suzuki, A. et al. Tricaprin rescues myocardial abnormality in a mouse model of triglyceride deposit cardiomyovasculopathy. J. Oleo. Sci. 67, 983\u2013989 (2018).","journal-title":"J. Oleo. Sci."},{"key":"611_CR15","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.5650\/jos.ess20185","volume":"69","author":"Y Hara","year":"2020","unstructured":"Hara, Y. et al. Effect of tricaprin on cardiac proteome in a mouse model for triglyceride deposit cardiomyovasculopathy. J. Oleo. Sci. 69, 1569\u20131577 (2020).","journal-title":"J. Oleo. Sci."},{"key":"611_CR16","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/eurheartj\/ehac762","volume":"44","author":"K Hirano","year":"2023","unstructured":"Hirano, K., Higashi, M. & Nakajima, K. Remarkable regression of diffuse coronary atherosclerosis in patients with triglyceride deposit cardiomyovasculopathy. Eur. Heart J. 44, 1191 (2023).","journal-title":"Eur. Heart J."},{"key":"611_CR17","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.cjco.2024.06.004","volume":"6","author":"H Yamamoto","year":"2024","unstructured":"Yamamoto, H., Ikeda, Y., Satomi, K. & Hirano, K. Acute coronary syndrome in a 40-year-old man with triglyceride deposit cardiomyovasculopathy: a case report. CJC Open 6, 1116\u20131120 (2024).","journal-title":"CJC Open"},{"key":"611_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/heartjnl-2020-317672","volume":"107","author":"T Onishi","year":"2021","unstructured":"Onishi, T. et al. Prevalence and clinical outcomes of triglyceride deposit cardiomyovasculopathy among haemodialysis patients. Heart 107, 127\u2013134 (2021).","journal-title":"Heart"},{"key":"611_CR19","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin, P. C. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat. Med. 28, 3083\u20133107 (2009).","journal-title":"Stat. Med."},{"key":"611_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/09-STS313","volume":"25","author":"EA Stuart","year":"2010","unstructured":"Stuart, E. A. Matching methods for causal inference: a review and a look forward. Stat. Sci. 25, 1\u201321 (2010).","journal-title":"Stat. Sci."},{"key":"611_CR21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","volume":"1","author":"JR Anderson","year":"1983","unstructured":"Anderson, J. R., Cain, K. C. & Gelber, R. D. Analysis of survival by tumor response. J. Clin. Oncol. 1, 710\u2013719 (1983).","journal-title":"J. Clin. Oncol."},{"key":"611_CR22","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.nmd.2014.04.001","volume":"24","author":"K Kaneko","year":"2014","unstructured":"Kaneko, K. et al. A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review. Neuromuscul. Disord. 24, 634\u2013641 (2014).","journal-title":"Neuromuscul. Disord."},{"key":"611_CR23","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/ehf2.14722","volume":"11","author":"Y Ikeda","year":"2024","unstructured":"Ikeda, Y. et al. Distinct myocardial triglyceride lipolysis pathways in primary and idiopathic triglyceride deposit cardiomyovasculopathy. ESC Heart Fail. 11, 1275\u20131278 (2024).","journal-title":"ESC Heart Fail."},{"key":"611_CR24","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1096\/fj.04-2263com","volume":"18","author":"S Sharma","year":"2004","unstructured":"Sharma, S. et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 18, 1692\u20131700 (2004).","journal-title":"FASEB J."},{"key":"611_CR25","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1007\/s00259-022-05749-1","volume":"49","author":"C Aoshima","year":"2022","unstructured":"Aoshima, C. et al. Clinical significance of 123I-BMIPP washout rate in patients with uncertain chronic heart failure. Eur. J. Nucl. Med. Mol. Imaging 49, 3129\u20133139 (2022).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"611_CR26","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0140-6736(16)30508-6","volume":"388","author":"C Wanner","year":"2016","unstructured":"Wanner, C., Amann, K. & Shoji, T. The heart and vascular system in dialysis. Lancet 388, 276\u2013284 (2016).","journal-title":"Lancet"},{"key":"611_CR27","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","volume":"382","author":"S Bangalore","year":"2020","unstructured":"Bangalore, S. et al. Management of coronary disease in patients with advanced kidney disease. N. Engl. J. Med. 382, 1608\u20131618 (2020).","journal-title":"N. Engl. J. Med."},{"key":"611_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/heartjnl-2020-318055","volume":"107","author":"K Nakajima","year":"2021","unstructured":"Nakajima, K. Triglyceride deposit cardiomyovasculopathy: how to recognise a new disease entity. Heart 107, 93\u201395 (2021).","journal-title":"Heart"},{"key":"611_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7793\/jcad.30.005","volume":"30","author":"K Hirano","year":"2024","unstructured":"Hirano, K. et al. Triglyceride deposit cardiomyovasculopathy manifesting coronary artery disease. J. Coron. Artery Dis. 30, 85\u201391 (2024).","journal-title":"J. Coron. Artery Dis."},{"key":"611_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000508346","volume":"83","author":"M Samukawa","year":"2020","unstructured":"Samukawa, M. et al. Neutral lipid storage disease associated with the PNPLA2 gene: case report and literature review. Eur. Neurol. 83, 317\u2013322 (2020).","journal-title":"Eur. Neurol."},{"key":"611_CR31","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.ekir.2021.07.013","volume":"6","author":"Y Nagasawa","year":"2021","unstructured":"Nagasawa, Y. et al. Genetic deficiency of adipose triglyceride lipase is associated with a novel type of podocytopathy. Kidney Int. Rep. 6, 2722\u20132725 (2021).","journal-title":"Kidney Int. Rep."},{"key":"611_CR32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJM196905082801906","volume":"280","author":"NJ Greenberger","year":"1969","unstructured":"Greenberger, N. J. & Skillman, T. G. Medium-chain triglycerides. N. Engl. J. Med. 280, 1045\u20131058 (1969).","journal-title":"N. Engl. J. Med."},{"key":"611_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2152\/jmi.54.385","volume":"54","author":"T Aoyama","year":"2007","unstructured":"Aoyama, T., Nosaka, N. & Kasai, M. Research on the nutritional characteristics of medium-chain fatty acids. J. Med. Invest. 54, 385\u2013388 (2007).","journal-title":"J. Med. Invest."},{"key":"611_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(17)30408-8","volume":"17","author":"K Augustin","year":"2018","unstructured":"Augustin, K. et al. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol. 17, 84\u201393 (2018).","journal-title":"Lancet Neurol."},{"key":"611_CR35","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3390\/nu12051473","volume":"12","author":"K Hagihara","year":"2020","unstructured":"Hagihara, K. et al. Promising effect of a new ketogenic diet regimen in patients with advanced cancer. Nutrients 12, 1473 (2020).","journal-title":"Nutrients"},{"key":"611_CR36","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1007\/BF00258103","volume":"12","author":"FF Knapp Jr","year":"1986","unstructured":"Knapp, F. F. Jr, Ambrose, K. R. & Goodman, M. M. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur. J. Nucl. Med. 12, S39\u2013S44 (1986).","journal-title":"Eur. J. Nucl. Med."},{"key":"611_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12350-010-9305-4","volume":"18","author":"N Tamaki","year":"2011","unstructured":"Tamaki, N. & Yoshinaga, K. Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. J. Nucl. Cardiol. 18, 135\u2013143 (2011).","journal-title":"J. Nucl. Cardiol."},{"key":"611_CR38","first-page":"757","volume":"37","author":"Y Fujibayashi","year":"1996","unstructured":"Fujibayashi, Y. et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J. Nucl. Med. 37, 757\u2013761 (1996).","journal-title":"J. Nucl. Med."},{"key":"611_CR39","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s12149-022-01787-9","volume":"36","author":"Z Chen","year":"2022","unstructured":"Chen, Z. et al. Methods of calculating 123I-\u03b2-methyl-P-iodophenyl-pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy. Ann. Nucl. Med. 36, 986\u2013997 (2022).","journal-title":"Ann. Nucl. Med."},{"key":"611_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/pin.12884","volume":"70","author":"M Tanaka","year":"2020","unstructured":"Tanaka, M. et al. A historical case of primary triglyceride deposit cardiomyovasculopathy. Pathol. Int. 70, 58\u201361 (2020).","journal-title":"Pathol. Int."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00611-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00611-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00611-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T13:58:25Z","timestamp":1742219905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00611-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["611"],"URL":"https:\/\/doi.org\/10.1038\/s44161-025-00611-7","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.H. has been a Joint Research Chair in collaboration with Toa Eiyo since February 2021 and has served as a medical adviser for Toa Eiyo since December 2021. K.H. has two granted (PCT\/JP2012\/071594 and PCT\/JP2021\/008689) and one patent pending (PCT\/JP2021\/025687). K.H. reports lecture fees from Nihon Medi-Physics. K.H. is the president (unpaid) of the Tochino Foundation and the Society of Triglyceride Biology and Medicine (TGBM). K.S. reports lecture fees from Bayer Yakuhin, Janssen Pharmaceutical, Novartis Pharma and Otsuka Pharmaceutical. H.M. has a patent granted (PCT\/JP2023\/032407) and is a director (unpaid) of TGBM. H.M. reports lecture fees from Nihon Medi-Physics and Toa Eiyo. Y. Nakano reports a grant from the Japan Society for the Promotion of Science outside the submitted work and lecture fees from Otsuka Pharma, Kowa, Astellas Pharma, AstraZeneca, Daiichi Sankyo and Ono Pharmaceutical. C.H. is a representative caretaker (unpaid) of the TGCV\/NLSD Patient Association, a director (unpaid) of TGBM and an employee of the Tochino Foundation. K. Nakajima receives funds for the endowed department (Functional Imaging and Artificial Intelligence, Kanazawa University) from Siemens Healthcare Japan, Nihon Medi-Physics (Japan) and PDRadiopharma (Japan); he has collaborated with Spectrum Dynamics Medical (Israel). S.Y. reports research grants from Nihon Medi-Physics and the Kowa Health Science Council. S.Y. is a representative director (unpaid) of Triglyceride Laboratory and Business and a managing director (paid) of the Tochino Foundation, which paid joint research fees to Osaka University. Y.Y. is a nutritional adviser (unpaid) for the TGCV\/NLSD Patient Association. Y.Y., N.Z. and Y. Ikeda have a patent granted (PCT\/JP2012\/071594). M.H. reports a Takeda Research Grant outside the submitted work and lecture fees from Sumitomo, Novartis, Ono, Kyowa-Kirin, Takeda, Eisai, Otsuka and Chugai. T.A. reports lecture fees from Astellas Pharma, AstraZeneca, Bayer, Daiichi Sankyo and Bristol Myers Squibb. S.F. reports lecture fees from Nihon Medi-Physics and Toa Eiyo Ltd. Y.S. reports collaborative research with TOSHIBA., Fuji Yakuhin and FornesLife, and speaker\/lecture fees from AstraZeneca, Ono Pharmaceutical, Eli Lilly, Kowa Pharmaceutical and Nippon Boehringer Ingelheim outside the submitted work. K.K. is a director (unpaid) of TGBM. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}